STOCK TITAN

NanoString to Webcast Presentation from the 11th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

NanoString Technologies (NASDAQ:NSTG) announced its participation in the 11th Annual SVB Leerink Global Healthcare Conference, scheduled for February 16-18, 2022. Brad Gray, President and CEO, will present on February 17, 2022, at 5:00 PM ET. The live webcast can be accessed through the company's investor section at www.nanostring.com. A replay of the presentation will be available one hour post-event and archived for 60 days. NanoString is known for its innovative life science tools, including the nCounter® Analysis System and GeoMx® Digital Spatial Profiler.

Positive
  • None.
Negative
  • None.

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 11th Annual SVB Leerink Global Healthcare Conference. The conference will be held virtually from February 16-18, 2022.

Brad Gray, president and chief executive officer, is scheduled to present on Thursday, February 17, 2022, at 5:00pm ET. Interested parties can access the live webcast with accompanying slides from the investor section of the company’s website at www.nanostring.com. The webcast replay will be available one hour after the conclusion of the live presentation and archived for 60 days.

About NanoString Technologies, Inc.

NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides platforms that allow researchers to map the universe of biology. The nCounter® Analysis System, cited in more than 5,200 peer-reviewed publications, offers a way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. NanoString’s GeoMx® Digital Spatial Profiler enables highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections, and has been cited in approximately 90 peer-reviewed publications. The CosMx Spatial Molecular Imager, with commercial availability expected in the second half of 2022, enables highly sensitive, high-resolution imaging of hundreds to thousands of RNAs or proteins directly from single cells within morphologically intact whole tissue sections.

For more information, please visit www.nanostring.com.

NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.

Doug Farrell

Vice President, Investor Relations & Corporate Communications

dfarrell@nanostring.com

Phone: 206-602-1768

Source: NanoString Technologies, Inc.

FAQ

What date is NanoString Technologies presenting at the SVB Leerink Global Healthcare Conference?

NanoString Technologies will present on February 17, 2022.

What time is NanoString's presentation at the conference?

The presentation is scheduled for 5:00 PM ET.

How can I access the NanoString Technologies webcast?

The webcast can be accessed at the investor section of NanoString's website, www.nanostring.com.

How long will the replay of NanoString's presentation be available?

The replay will be available one hour after the presentation and will be archived for 60 days.

What innovative tools does NanoString Technologies provide for life science research?

NanoString provides tools like the nCounter® Analysis System and GeoMx® Digital Spatial Profiler.

NanoString Technologies, Inc.

NASDAQ:NSTG

NSTG Rankings

NSTG Latest News

NSTG Stock Data

5.07M
39.41M
3.17%
106.45%
12.55%
Medical Instruments & Supplies
Healthcare
Link
United States
Seattle